AT1 8.33% 2.2¢ atomo diagnostics limited

Ann: Atomo and Access Bio renegotiate supply agreements, page-16

  1. 227 Posts.
    lightbulb Created with Sketch. 60
    HIV was Atomo's main business pre-COVID-19, so this entire COVID-19 market opportunity is really just a bonus, but a welcomed one.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.